These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 35171063)
1. Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs. Liang R; Ge W; Li B; Cui W; Ma X; Pan Y; Li G Pharm Biol; 2022 Dec; 60(1):359-373. PubMed ID: 35171063 [TBL] [Abstract][Full Text] [Related]
2. Synergistic interaction between genetics and disease on pravastatin disposition. Clarke JD; Hardwick RN; Lake AD; Lickteig AJ; Goedken MJ; Klaassen CD; Cherrington NJ J Hepatol; 2014 Jul; 61(1):139-47. PubMed ID: 24613363 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease. Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714 [TBL] [Abstract][Full Text] [Related]
5. The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats. Badolo L; Bundgaard C; Garmer M; Jensen B Eur J Pharm Sci; 2013 Jul; 49(4):767-72. PubMed ID: 23648783 [TBL] [Abstract][Full Text] [Related]
6. A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model. Montonye ML; Tian DD; Arman T; Lynch KD; Hagenbuch B; Paine MF; Clarke JD J Pharmacol Exp Ther; 2019 Nov; 371(2):385-393. PubMed ID: 31420525 [TBL] [Abstract][Full Text] [Related]
9. Effect of oxidative stress on expression and function of human and rat organic anion transporting polypeptides in the liver. Tsujimoto T; Ogura J; Kuwayama K; Koizumi T; Sasaki S; Terada Y; Kobayashi M; Yamaguchi H; Iseki K Int J Pharm; 2013 Dec; 458(2):262-71. PubMed ID: 24409515 [TBL] [Abstract][Full Text] [Related]
10. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin. Niemi M; Pasanen MK; Neuvonen PJ Clin Pharmacol Ther; 2006 Oct; 80(4):356-66. PubMed ID: 17015053 [TBL] [Abstract][Full Text] [Related]
11. Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats. Fisher CD; Lickteig AJ; Augustine LM; Oude Elferink RP; Besselsen DG; Erickson RP; Cherrington NJ Eur J Pharmacol; 2009 Jun; 613(1-3):119-27. PubMed ID: 19358839 [TBL] [Abstract][Full Text] [Related]
12. Orange juice increased the bioavailability of pravastatin, 3-hydroxy-3-methylglutaryl CoA reductase inhibitor, in rats and healthy human subjects. Koitabashi Y; Kumai T; Matsumoto N; Watanabe M; Sekine S; Yanagida Y; Kobayashi S Life Sci; 2006 May; 78(24):2852-9. PubMed ID: 16412477 [TBL] [Abstract][Full Text] [Related]
13. Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril. Maeda K; Ieiri I; Yasuda K; Fujino A; Fujiwara H; Otsubo K; Hirano M; Watanabe T; Kitamura Y; Kusuhara H; Sugiyama Y Clin Pharmacol Ther; 2006 May; 79(5):427-39. PubMed ID: 16678545 [TBL] [Abstract][Full Text] [Related]
15. Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin. Igel M; Arnold KA; Niemi M; Hofmann U; Schwab M; Lütjohann D; von Bergmann K; Eichelbaum M; Kivistö KT Clin Pharmacol Ther; 2006 May; 79(5):419-26. PubMed ID: 16678544 [TBL] [Abstract][Full Text] [Related]
16. Treatment with geraniol ameliorates methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in rats. Chen J; Fan X; Zhou L; Gao X J Gastroenterol Hepatol; 2016 Jul; 31(7):1357-65. PubMed ID: 26695085 [TBL] [Abstract][Full Text] [Related]
17. Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics. Becquemont L; Neuvonen M; Verstuyft C; Jaillon P; Letierce A; Neuvonen PJ; Funck-Brentano C Clin Pharmacol Ther; 2007 May; 81(5):679-84. PubMed ID: 17301736 [TBL] [Abstract][Full Text] [Related]
18. Characterization of Long-Lasting Oatp Inhibition by Typical Inhibitor Cyclosporine A and In Vitro-In Vivo Discrepancy in Its Drug Interaction Potential in Rats. Taguchi T; Masuo Y; Kogi T; Nakamichi N; Kato Y J Pharm Sci; 2016 Jul; 105(7):2231-9. PubMed ID: 27290622 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment. Wu LX; Guo CX; Chen WQ; Yu J; Qu Q; Chen Y; Tan ZR; Wang G; Fan L; Li Q; Zhang W; Zhou HH Br J Clin Pharmacol; 2012 May; 73(5):750-7. PubMed ID: 22114872 [TBL] [Abstract][Full Text] [Related]
20. Organic anion-transporting polypeptides 1a/1b control the hepatic uptake of pravastatin in mice. Iusuf D; Sparidans RW; van Esch A; Hobbs M; Kenworthy KE; van de Steeg E; Wagenaar E; Beijnen JH; Schinkel AH Mol Pharm; 2012 Sep; 9(9):2497-504. PubMed ID: 22812517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]